Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4

Advanced Science(2024)10.1002/advs.202309642Source: DataRank Database

Cholesterol 25‐Hydroxylase Protects Against Diabetic Kidney Disease by Regulating ADP Ribosylation Factor 4 is a research paper published in Advanced Science (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 3.93)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Zhengying Fang,Qingqing Zhu ORCID,Shumin Yang ORCID,Jia Fu ORCID,Zeguo Sun ORCID

Live enrichment

PubMed:38816950 PMC:PMC11304234 OpenAlex:https://openalex.org/W4399246552

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK129467

NIDDK NIH HHS

Grant: K01 DK125614

NIDDK NIH HHS

Grant: R01 DK109683

NIH/NIDDK

Grant: 1R01DK133912

BLRD VA

Grant: I01 BX000345

NIDDK NIH HHS

Grant: R01 DK117913

NIDDK NIH HHS

Grant: R01 DK122980

NIH/NIDDK

Grant: R01DK117913-01

NIDDK NIH HHS

Grant: R01 DK133912

FWCI

3.93

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202309642

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202309642

publisherhttps://advanced.onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202309642

journalhttps://doi.org/10.1002/advs.202309642

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38816950

Fields of Study

Cholesterol and Lipid MetabolismCancer, Lipids, and MetabolismLiver Disease Diagnosis and TreatmentAnimalsHumansMaleMiceADP-Ribosylation FactorsDiabetic NephropathiesDisease Models, AnimalHydroxycholesterolsMice, Inbred C57BLSteroid Hydroxylases

MeSH Terms

AnimalsDiabetic NephropathiesDisease Models, AnimalHumansHydroxycholesterolsMaleMice, Inbred C57BLSteroid HydroxylasesADP-Ribosylation FactorsMice

Keywords

Diabetes mellitusKidney diseaseMedicineCholesterolEndocrinologyInternal medicinePharmacologyChemistryGolgi apparatusGlomerular endothelial cellsDiabetic Kidney Diseases

Sustainable Development Goals

SDG 0: Good health and well-being